We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Nanoco | AQSE:NANO.GB | Aquis Stock Exchange | Ordinary Share | GB00B01JLR99 | Ordinary Shares 10p |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 20.00 | 19.00 | 21.00 | 20.00 | 19.481 | 20.00 | 30,929 | 16:29:52 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMNANO
RNS Number : 5996M
Nanoco Group PLC
14 October 2016
For immediate release 14 October 2016
NANOCO GROUP PLC
("Nanoco" or the "Company" or "Group")
Director Share Purchase
Nanoco Group plc (LSE: NANO), a world leader in the development and manufacture of cadmium-free quantum dots and other nanomaterials, received notification today that Dr Christopher Richards, Non-Executive Chairman, purchased 55,576 ordinary shares of GBP0.10 each ("Ordinary Shares") in the Company on 14 October 2016 at a price of 53.98p per Ordinary Share, in the name of his wife, Ann Carolyn Richards.
Following this transaction, Christopher has a beneficial interest in 98,997 Ordinary Shares (of which 73,120 are held by his wife, Ann Carolyn Richards), representing approximately 0.04 per cent. of the total voting rights in the Company.
The notification below, made in accordance with the requirements of the EU Market Abuse Regulation, provides further detail.
1 Details of the person discharging managerial responsibilities/person closely associated --- --------------------------------------------------------- a) Name Christopher Richards --- ------------------------------- ------------------------ 2 Reason for the notification --- --------------------------------------------------------- a) Position/status Non-Executive Chairman --- ------------------------------- ------------------------ b) Initial notification/Amendment Initial notification --- ------------------------------- ------------------------ 3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor --- --------------------------------------------------------- a) Name Nanoco Group plc --- ------------------------------- ------------------------ b) LEI England & Wales Company Number: 05067291 --- ------------------------------- ------------------------ 4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted --- --------------------------------------------------------- a) Description of the Ordinary Shares financial instrument, type of instrument --- ------------------------------- ------------------------ Identification code NANO ISIN GB00B01JLR99 --- ------------------------------- ------------------------ b) Nature of the transaction Acquisition of Ordinary Shares --- ------------------------------- ------------------------ c) Price(s) and volume(s) Price(s) 53.98p Volume(s) 55,576 --- ------------------------------- ------------------------ d) Aggregated information Price(s) 53.98p Volume(s) 55,576 --- ------------------------------- ------------------------ e) Date of transaction 14 October 2016 --- ------------------------------- ------------------------ f) Place of transaction London Stock Exchange --- ------------------------------- ------------------------
For further information, please contact:
Nanoco Tel: +44 (0) 161 603 7900 Michael Edelman, Chief Executive Officer David Blain, Chief Financial Officer Caroline Watson, Investor Tel: + 44 (0) 7799 Relations Manager 897357 cwatson@nanocotechnologies.com Tel: +44 (0) 20 7418 Peel Hunt 8900 Adrian Trimmings George Sellar Tel: +44 (0) 20 7466 Buchanan 5000 Mark Court / Sophie Cowles / Stephanie Watson
Notes for editors:
About Nanoco Group plc
Nanoco is a world leader in the development and production of cadmium-free quantum dots and other nanomaterials for use in multiple applications including LCD displays, lighting, solar cells and bio-imaging. In the display market, Nanoco has non-exclusive manufacturing and marketing licensing agreements with The Dow Chemical Company, Merck KGaA and Taiwan's Wah Hong Industrial Corporation. Nanoco also has a strategy of direct sales in display and in its other target markets, including lighting.
Nanoco was founded in 2001 and is headquartered in Manchester, UK. It has production facilities in Runcorn, UK, and a US subsidiary, Nanoco Inc, based in Concord, MA. Nanoco also has business development executives in Japan, Korea and Greater China. Its technology is protected worldwide by a large and growing patent estate.
Nanoco is listed on the main market of the London Stock Exchange and trades under the ticker symbol NANO. For further information please visit: www.nanocogroup.com.
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHEAFELFLFKFFF
(END) Dow Jones Newswires
October 14, 2016 07:45 ET (11:45 GMT)
1 Year Nanoco Chart |
1 Month Nanoco Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions